Can the right dose and timing of steroids save more lives in ARDS?

NCT ID NCT07711964

Recruiting now Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial investigates whether different doses and durations of the corticosteroid dexamethasone improve outcomes for adults with acute respiratory distress syndrome (ARDS) who are on a ventilator. Participants are randomly assigned to receive either no steroids, a low or medium dose for 7 or 10 days. The study aims to find the best balance of dose and treatment length to increase survival without the need for a ventilator.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dexamethasone (a corticosteroid) given at low or medium dose for 7 or 10 days
What this could lead to: If successful, this trial could identify the most effective dose and duration of corticosteroids for ARDS, potentially improving survival and reducing time on a ventilator.
What could go wrong: This is a proof-of-concept trial, so results are preliminary. Corticosteroids have known risks like infection and bleeding, and the optimal regimen may still not be clear after this study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory distress syndrome adult acute respiratory distress syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Taiwan University Hospital
RECRUITING

Taipei, 10002, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.